These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 7221526)

  • 21. Disposition of didanosine in HIV-seropositive patients with normal renal function or chronic renal failure: influence of hemodialysis and continuous ambulatory peritoneal dialysis.
    Knupp CA; Hak LJ; Coakley DF; Falk RJ; Wagner BE; Raasch RH; van der Horst CM; Kaul S; Barbhaiya RH; Dukes GE
    Clin Pharmacol Ther; 1996 Nov; 60(5):535-42. PubMed ID: 8941026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Absorption and disposition kinetics of flunoxaprofen and benoxaprofen in healthy volunteers.
    Furlanut M; Montanari G; Perosa A; Velussi C; Forgione A; Palatini P
    Int J Clin Pharmacol Res; 1985; 5(3):165-70. PubMed ID: 4018949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pharmacokinetics and acceptability of benoxaprofen following rectal administration.
    Jones RW; Waugh AE; Woodage TJ; Wild RN; Glynne A
    J Rheumatol Suppl; 1980; 6():20-6. PubMed ID: 6930484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and pharmacodynamics of lobaplatin (D-19466) in patients with advanced solid tumors, including patients with impaired renal of liver function.
    Welink J; Boven E; Vermorken JB; Gall HE; van der Vijgh WJ
    Clin Cancer Res; 1999 Sep; 5(9):2349-58. PubMed ID: 10499604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum levels and half-life of sotalol in chronic renal failure.
    Sundquist HK; Anttila M; Forsström J; Kasanen A
    Ann Clin Res; 1975 Dec; 7(6):442-6. PubMed ID: 1211858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.
    Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic profiles of intravenous imipenem/cilastatin during slow hemodialysis in critically ill patients.
    Kihara M; Ikeda Y; Shibata K; Masumori S; Ebira H; Shiratori K; Ueda S; Takagi N; Umemura S; Shionoiri H
    Clin Nephrol; 1994 Sep; 42(3):193-7. PubMed ID: 7994939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E; Cloyd J; Critchley D; Fuseau E
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Garenoxacin pharmacokinetics in subjects with renal impairment.
    Krishna G; Gajjar D; Swan S; Marbury T; Grasela DM; Wang Z
    Curr Med Res Opin; 2007 Mar; 23(3):649-57. PubMed ID: 17355746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of renal function on the elimination kinetics of sulbenicillin in man.
    Montanari A; Borghi L; Canali M; Coruzzi P; Novarini A; Borghetti A
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):225-8. PubMed ID: 7390672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of Damvar.
    Grafnetterová J; Janků I; König J; Krebs V; Ackerman R
    Neoplasma; 1982; 29(2):223-32. PubMed ID: 7110448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of almitrine bismesylate: studies in patients.
    Bromet N; Courte S; Aubert Y; Baune A; Balem MP; du Vignaud P
    Eur J Respir Dis Suppl; 1983; 126():363-75. PubMed ID: 6586449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Independent of etozolin elimination of kidney function. Single dose experiments in patients with renal insufficiency.
    Knauf H; Hasenfuss G; Wais U; Schollmeyer P; Mutschler E
    Arzneimittelforschung; 1980; 30(10):1791-3. PubMed ID: 7192116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Benoxaprofen in the treatment of spondylosis and spondylarthrosis (author's transl)].
    Hevelke G; Schilling E
    MMW Munch Med Wochenschr; 1981 Oct; 123(41):1543-8. PubMed ID: 6795469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical pharmacology of mitoxantrone.
    Ehninger G; Proksch B; Heinzel G; Woodward DL
    Cancer Treat Rep; 1986 Dec; 70(12):1373-8. PubMed ID: 3791250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Studies on the pharmacokinetics of pipemidic acid in renal insufficiency (author's transl)].
    Brühl P; Köhler T; Gundlach G; Krasemann C
    Arzneimittelforschung; 1981; 31(10):1766-70. PubMed ID: 7198452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overview of acylureidopenicillin pharmacokinetics.
    Bergan T
    Scand J Infect Dis Suppl; 1981; 29():33-48. PubMed ID: 7031864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absorption and disposition of ibuprofen in hemodialyzed uremic patients.
    Senekjian HO; Lee CS; Kuo TH; Au DS; Krothapalli R
    Eur J Rheumatol Inflamm; 1983; 6(2):155-62. PubMed ID: 6673979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of cefalexin pharmacokinetics and dosage adjustments in relation to renal function.
    Brogard JM; Pinget M; Dorner M; Lavillaureix J
    J Clin Pharmacol; 1975 Oct; 15(10):666-73. PubMed ID: 1184770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cefamandole pharmacokinetics and dosage adjustments in relation to renal function.
    Brogard JM; Kopferschmitt J; Spach MO; Grudet O; Lavillaureix J
    J Clin Pharmacol; 1979 Jul; 19(7):366-77. PubMed ID: 479381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.